Transforming from biotech to biopharma: creating a new value chain to serve unmet patient needs.

Discover how Galapagos’ supply chain acted as the backbone of their transformation from a biotech to a biopharma company.

By Wouter Keymeulen, VP Quality Galapagos, and Pieter Van den Meutter, Head of Customer Intelligence bluecrux

Fill in the form below to receive your on-demand presentation!

Scroll to Top